drugset / Trial / NCT05216172
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
RandomizedParallel-groupQuadruple-blindTreatment
Summary
AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce: a single site, placebo-controlled, double-blind randomised clinical trial of AZD1656 in renal transplant patients with Type 2 diabetes
Timeline
- Start
- 2019-12-13
- Primary completion
- 2022-09-11
- Completion
- 2022-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1656 | Small molecule | 100 mg | — |